- Report
- February 2024
- 250 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- November 2024
- 79 Pages
Global
From €5330EUR$5,600USD£4,474GBP
- Report
- October 2024
- 193 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 189 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 196 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 199 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 184 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 190 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 191 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 186 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- August 2024
- 100 Pages
Global
From €5663EUR$5,950USD£4,753GBP
- Report
- July 2024
- 120 Pages
Global
From €5663EUR$5,950USD£4,753GBP
- Report
- February 2024
- 175 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- February 2024
- 250 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- February 2024
- 175 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- February 2024
- 175 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- January 2024
- 200 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- July 2024
- 175 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- July 2024
- 175 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- July 2024
- 175 Pages
Global
From €4759EUR$5,000USD£3,994GBP
The Immunosuppressive Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that suppress the immune system. These drugs are used to treat autoimmune diseases, organ transplant rejection, and other conditions where the immune system is overactive. Immunosuppressive drugs work by blocking the action of certain cells in the immune system, preventing them from attacking healthy tissue.
Immunosuppressive drugs are typically administered orally or intravenously, and can be used in combination with other treatments such as steroids or chemotherapy. Common side effects of immunosuppressive drugs include nausea, vomiting, diarrhea, and increased risk of infection.
Some of the major companies in the Immunosuppressive Drugs market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more